Literature DB >> 11454847

Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.

C Berry, N Anderson, A J Kirk, A F Dominiczak, J J McMurray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11454847      PMCID： PMC1729836          DOI： 10.1136/heart.86.2.217

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  26 in total

1.  National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?

Authors:  C J Knight
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 2.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

3.  The diagnosis of heart failure.

Authors:  A D Struthers
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

4.  Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.

Authors:  O W Nielsen; J F Hansen; J Hilden; C T Larsen; J Svanegaard
Journal:  BMJ       Date:  2000-01-22

5.  Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.

Authors:  C Berry; C A Hamilton; M J Brosnan; F G Magill; G A Berg; J J McMurray; A F Dominiczak
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

6.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.

Authors:  T J Guzik; N E West; E Black; D McDonald; C Ratnatunga; R Pillai; K M Channon
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

Review 7.  The taxanes: an update.

Authors:  J Crown; M O'Leary
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

8.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

9.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors:  P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

10.  Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries.

Authors:  C Huraux; T Makita; S Kurz; K Yamaguchi; F Szlam; M M Tarpey; J N Wilcox; D G Harrison; J H Levy
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690
View more
  5 in total

Review 1.  Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

Authors:  Jesse Dawson; Matthew Walters
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

2.  Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007.

Authors:  Christian Delles; Jane A Dymott; Ulf Neisius; J Paul Rocchiccioli; Gavin J Bryce; María U Moreno; David M Carty; Geoffrey A Berg; Carlene A Hamilton; Anna F Dominiczak
Journal:  Atherosclerosis       Date:  2010-01-21       Impact factor: 5.162

Review 3.  Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

Authors:  Jeanette Schultz Johansen; Alex K Harris; David J Rychly; Adviye Ergul
Journal:  Cardiovasc Diabetol       Date:  2005-04-29       Impact factor: 9.951

Review 4.  What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Clin Interv Aging       Date:  2013-11-14       Impact factor: 4.458

5.  Decrease in exhaled hydrogen as marker of congestive heart failure.

Authors:  Atsushi Shibata; Yasuo Sugano; Akito Shimouchi; Tetsuro Yokokawa; Naoya Jinno; Hideaki Kanzaki; Keiko Ohta-Ogo; Yoshihiko Ikeda; Hideshi Okada; Takeshi Aiba; Kengo Kusano; Mikiyasu Shirai; Hatsue Ishibashi-Ueda; Satoshi Yasuda; Hisao Ogawa; Toshihisa Anzai
Journal:  Open Heart       Date:  2018-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.